In Vivo Models for Drug Discovery

In vivo pharmacology is essential to evaluate the complex physiological effects of a drug in living organism. WuXi Biology provides in vivo pharmacology studies to evaluate the efficacy, safety and early toxicity of small molecules & biologics. WuXi Biology’s broad expertise and years of preclinical pharmacology experience makes us the ideal partner to conduct your in vivo experiments in all disease areas.

Disease-centric, with animal models in rodents and NHPs, expending to age-related diseases

Preclinical Integrated Services

in vitro biology, PK-PD and toxicology studies to provide datasets and evidence for IND-enabling

Our scientists provide drug discovery services and tailored solutions to advance your drug candidate selection in multiple disease areas. Through comprehensive discovery and technology platforms, peer-recognized scientific leadership and expertise in oncology, immunology, infectious disease, neurosciences, fibrosis, cardiovascular and metabolic disease, our teams  work collaboratively to rapidly advance programs from target through to preclinical selection and beyond.

Therapeutic areas include:


Autoimmune and Inflammatory diseases

Oncology & Immuno-oncology

Cardiovascular & Metabolic diseases

Liver diseases

Infectious diseases

Respiratory diseases